Research identifies possible new pathway to treatment of colorectal cancer

(From left) Kristin Eden, Brie Trusiano, and Irving Coy Allen. Credit: Madison Brown, Virginia Tech Research led by Irving Coy Allen in the Virginia-Maryland College of Veterinary Medicine has unlocked a pathway to possible future treatments for colorectal cancer in humans. A paper published in May in Cellular and Molecular Gastroenterology and Hepatology focuses on NF-kB-inducing kinase (NIK) and its importance in triggering cellular responses that reduce the risk of the development of colorectal cancer. “The gene itself is colloquially called NIK, and it encodes a protein that is a Read More

Related posts:

  1. Study identifies potential pathway to reducing breast cancer brain metastases
  2. Potential new target for colorectal cancer treatment
  3. Research confirms circZFR is a promising biomarker for colorectal cancer diagnosis and prognosis
  4. Successful trial for new colorectal cancer treatment highlights promising immunotherapy drugs
  5. Researchers detail molecular pathway that impacts pancreatic cancer progression and treatment response
  6. The current status of colorectal cancer in Thailand
  7. Immunotherapy before surgery very successful in treating colorectal cancer, trial finds
  8. Study reveals metformin’s role in slowing colorectal cancer cell growth

Leave a Reply

Your email address will not be published. Required fields are marked *